ARGENX SE
Company Information
Industry
Biological Products, (No Diagnostic Substances)
SIC Code
2836
Entity Type
other
SEC Category
Large accelerated filer
State of Incorporation
Netherlands
Country
Belgium
Business Address
INDUSTRIEPARK ZWIJNAARDE 7, ZWIJNAARDE, ,
Mailing Address
INDUSTRIEPARK ZWIJNAARDE 7, ZWIJNAARDE, ,
Phone
32 (9) 310 34 00
Fiscal Year End
1231
EIN
000000000
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 6-K Foreign company current report | March 20, 2026 | View on SEC |
| 6-K Foreign company current report | March 19, 2026 | View on SEC |
| 20-F Foreign company annual report | March 19, 2026 | View on SEC |
| 6-K Foreign company current report | March 6, 2026 | View on SEC |
| 6-K Foreign company current report | February 26, 2026 | View on SEC |
| 6-K Foreign company current report | February 26, 2026 | View on SEC |
| 6-K Foreign company current report | January 13, 2026 | View on SEC |
| 6-K Foreign company current report | January 12, 2026 | View on SEC |
| 6-K Foreign company current report | January 5, 2026 | View on SEC |
| 6-K Foreign company current report | December 15, 2025 | View on SEC |
Annual Reports
20-F
March 19, 2026
- VYVGART's exceptional global sales of $1.20 billion in 2023, driving 158% overall sales growth to $1.23 billion.
- Successful expansion of VYVGART's market with U.S. FDA approval of subcutaneous VYVGART Hytrulo and approval for CIDP in June 2024.
Related Companies
Companies in the same industry (SIC: 2836)
Cardiff Oncology, Inc.
CRDF
Biological Products, (No Diagnostic Substances)
Voyager Therapeutics, Inc.
VYGR
Biological Products, (No Diagnostic Substances)
HALOZYME THERAPEUTICS, INC.
HALO
Biological Products, (No Diagnostic Substances)
Immunovant, Inc.
IMVT
Biological Products, (No Diagnostic Substances)
Adaptive Biotechnologies Corp
ADPT
Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.